Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | KMT2D | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AFAP1L1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | KCNB2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | SPPL2B | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SLC29A4 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | TP53BP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | OSER1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |